Newly updated advice on using DMARDs for RA

INTRODUCTION Shared decision-making between patients and doctors is a central focus of newly updated recommendations on treating rheumatoid arthritis with disease-modifying antirheumatic drugs (DMARDs). The updated recommendations, produced by the European League Against Rheumatism (EULAR), also take into account recent research on the benefits and safety of these widely used drugs. WHAT DO WE KNOW ALREADY? When […]

Read More…